1. 1815 A double blind phase 3 trial of fulvestrant with placebo or palbociclib in pre- and post-menopausal women with hormone receptor-positive (HR+ve), HER2-negative (HER2-ve) metastatic breast cancer (MBC) that progressed on prior endocrine therapy (PALOMA 3): Detailed analysis of patient-reported outcomes. (September 2015) Authors: Harbeck, N.; Cristofanilli, M.; Ro, J.; André, F.; Loi, S.; Verma, S.; Iwata, H.; Loibl, S.; Huang Bartlett, C.; Zhang, K.; Iyer, S.; Thiele, A.; Theall, K.; Koehler, M.; Turner, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1829 Locoregional recurrence by tumor biology in breast cancer patients after preoperative chemotherapy and breast conservation treatment. (September 2015) Authors: Jwa, E.; Shin, K.H.; Kim, J.Y.; Jung, S.Y.; Lee, E.S.; Park, I.H.; Lee, K.S.; Ro, J.; Kim, Y.J.; Kim, T.H. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC). (September 2015) Authors: Miles, D.; Cameron, D.; Bondarenko, I.; Lyudmila, M.; Alcedo, J.C.; Lopez, R.I.; Im, S.A.; Canon, J.L.; Shparyk, Y.; Yardley, D.; Masuda, N.; Ro, J.; Hubeaux, S.; Quah, C.; Bais, C.; O'Shaughnessy, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 250PA global phase III clinical study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients. (18th September 2017) Authors: Saeki, T.; Mukai, H.; Ro, J.; Lin, Y-C.; Fujiwara, Y.; Nagai, S.; Lee, K.S.; Watanabe, J.; Ohtani, S.; Kim, S.B.; Kuroi, K.; Tsugawa, K.; Tokuda, Y.; Iwata, H.; Park, Y.H.; Yang, Y.; Nambu, Y. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Performance Characteristics of Active Constrained Layer Damping. (1995) Authors: Baz, A.; Ro, J. Journal: Shock and vibration Issue: Volume 1995(1995) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial. (30th March 2016) Authors: Harbeck, N.; Iyer, S.; Turner, N.; Cristofanilli, M.; Ro, J.; André, F.; Loi, S.; Verma, S.; Iwata, H.; Bhattacharyya, H.; Puyana Theall, K.; Bartlett, C. H.; Loibl, S. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗